ClinicalTrials.govpublic full text
A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS
acute myelogenous leukemia in relapse, acute myelogenous leukemia, relapsed, adult, acute myelogenous leukemia, adult, acute myelogenous leukemia, high risk myelodysplasia, aml, mds, leukemia, acute myeloid leukemia, aptose, apto-253, kinase inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 908025
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.